NovAccess Global Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements
NovAccess Global Receives FDA Approval of Orphan Drug Application for TLR-AD1
NovAccess Global Closes its Redemption Transaction and expands the Executive Board
